pantoprazole has been researched along with Asthma in 8 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To define the prevalence of gastroesophageal reflux disease (GERD) in mild persistent asthma and to value the effect of pantoprazole therapy on asthmatic symptoms." | 7.73 | Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. ( Areni, A; Calabrese, C; Di Febo, G; Fabbri, A; Scialpi, C; Zahlane, D, 2005) |
| "The combination of bronchial asthma with pathology of the digestive tract--one of the most frequent, clinically diverse and difficult, which complicates its course." | 5.39 | [Comparison of the effectiveness of omeprazole and pantoprazole treatment of gastroesophageal reflux disease in patients with asthma]. ( Popadynets', IR, 2013) |
| "To define the prevalence of gastroesophageal reflux disease (GERD) in mild persistent asthma and to value the effect of pantoprazole therapy on asthmatic symptoms." | 3.73 | Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. ( Areni, A; Calabrese, C; Di Febo, G; Fabbri, A; Scialpi, C; Zahlane, D, 2005) |
| "The combination of bronchial asthma with pathology of the digestive tract--one of the most frequent, clinically diverse and difficult, which complicates its course." | 1.39 | [Comparison of the effectiveness of omeprazole and pantoprazole treatment of gastroesophageal reflux disease in patients with asthma]. ( Popadynets', IR, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popadynets', IR | 1 |
| Bucknall, C | 1 |
| Stanton, A | 1 |
| Miller, G | 1 |
| Rajoriya, N | 1 |
| Babu, S | 1 |
| Mackenzie, J | 1 |
| Cortes, JR | 1 |
| Rivas, MD | 1 |
| Molina-Infante, J | 1 |
| Gonzalez-Nuñez, MA | 1 |
| Perez-G, M | 1 |
| Masa, JF | 1 |
| Sanchez, JF | 1 |
| Zamorano, J | 1 |
| Barbato, A | 1 |
| Panizzolo, C | 1 |
| Landi, L | 1 |
| Semenzato, R | 1 |
| Rugge, M | 1 |
| Katz, PO | 1 |
| Calabrese, C | 1 |
| Fabbri, A | 1 |
| Areni, A | 1 |
| Scialpi, C | 1 |
| Zahlane, D | 1 |
| Di Febo, G | 1 |
| Eryuksel, E | 1 |
| Dogan, M | 1 |
| Golabi, P | 1 |
| Sehitoglu, MA | 1 |
| Celikel, T | 1 |
1 review available for pantoprazole and Asthma
| Article | Year |
|---|---|
Gastroesophageal reflux disease and extraesophageal disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Benzimidazoles; Esophageal pH Mo | 2005 |
7 other studies available for pantoprazole and Asthma
| Article | Year |
|---|---|
[Comparison of the effectiveness of omeprazole and pantoprazole treatment of gastroesophageal reflux disease in patients with asthma].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Asthma; Female; | 2013 |
The impact of normalization of esophageal acid profile by incremental protein pump inhibitors dosing in difficult asthma patients with proven gastro-esophageal acid reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Asthma; Dose-Response Relationship, Drug; Esop | 2009 |
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Asthma; Cell Line, Tumor; Disease Models, Animal; | 2009 |
Asthma-like syndrome in a teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Albuterol; Amoxicillin; Androstadienes; Anti-Ba | 2003 |
[Attention! Cough, asthma and Co. are often caused by reflux].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Clinical | 2004 |
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Female; F | 2005 |
Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Combined | 2006 |